Log In
Print
BCIQ
Print
Print this Print this
 

suvorexant (MK-4305)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionDual orexin receptor antagonist
Molecular Target Orexin 1 receptor (HCRTR1) (OX1R) ; Orexin 2 receptor (HCRTR2) (OX2R)
Mechanism of ActionOrexin receptor antagonist
Latest Stage of DevelopmentRegistration
IndicationInsomnia
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today